Document Detail


An In Vitro Diagnostic Multivariate Index Assay (IVDMIA) for Ovarian Cancer: Harvesting the Power of Multiple Biomarkers.
MedLine Citation:
PMID:  22582125     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
In this review, OVA1® (Vermillion, Inc., Austin, TX), the first in vitro diagnostic multivariate index assay (IVDMIA) of protein biomarkers cleared by the US Food and Drug Administration (FDA), is used to explain the concept behind IVDMIA, the use of multiple markers to improve clinical performance of a diagnostic tool, and the key considerations in the development of IVDMIA.
Authors:
Zhen Zhang
Related Documents :
8929745 - Pharmacokinetics of thiamine derivatives especially of benfotiamine.
9267685 - Effects of food, antacid, and dosage form on the pharmacokinetics and relative bioavail...
2322635 - Absence of effect of food on alprazolam absorption from sustained release tablets.
11781675 - Cholesterol-lowering effects of plant sterol esters and non-esterified stanols in marga...
8706915 - Presence of epsilon-adenosine tetraphosphate in chromaffin granules after transport of ...
22834755 - Dietary hardness, loading behavior, and the evolution of skull form in bats.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Reviews in obstetrics & gynecology     Volume:  5     ISSN:  2153-8166     ISO Abbreviation:  Rev Obstet Gynecol     Publication Date:  2012  
Date Detail:
Created Date:  2012-05-14     Completed Date:  2012-10-02     Revised Date:  2014-08-28    
Medline Journal Info:
Nlm Unique ID:  101479674     Medline TA:  Rev Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  35-41     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comprehensive surgical staging for endometrial cancer.
Next Document:  Genetic testing for lynch syndrome, an inherited cancer of the bowel, endometrium, and ovary.